NCT04361513View on ClinicalTrials.gov

Genicular Nerve Block in Rheuamtoid Arthritis

PHASE4CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

April 15, 2020

Primary Completion Date

July 28, 2020

Study Completion Date

July 28, 2020

Conditions
PainJoint Function DisorderInflammation
Interventions
DRUG

Bupivacaine hydrochloride 0.5% (Marcaine, Pfizer)

3 point genicular nerve block

DRUG

triamcinolone 40 milligrams (Kenacort, Bristol Myers Squip)

intra-articular injection of triamcinilone

Trial Locations (1)

82749

Minia university, Minya

All Listed Sponsors
lead

Sohag University

OTHER

NCT04361513 - Genicular Nerve Block in Rheuamtoid Arthritis | Biotech Hunter | Biotech Hunter